Yang HB - Search Results

1

SMAD4 suppresses AURKA-induced metastatic phenotypes via degradation of AURKA in a TGFβ-independent manner.

Jia L, Lee HS, Wu CF, Kundu J, Park SG, Kim RN, Wang LH, Erkin ÖC, Choi JS, Chae SW, Yang HB, Choi YL, Shin YK. Jia L, et al. Among authors: yang hb. Mol Cancer Res. 2014 Dec;12(12):1779-95. doi: 10.1158/1541-7786.MCR-14-0191. Epub 2014 Jul 24. Mol Cancer Res. 2014. PMID: 25061104

2

Low SP1 expression differentially affects intestinal-type compared with diffuse-type gastric adenocarcinoma.

Lee HS, Park CK, Oh E, Erkin ÖC, Jung HS, Cho MH, Kwon MJ, Chae SW, Kim SH, Wang LH, Park MJ, Lee SY, Yang HB, Jia L, Choi YL, Shin YK. Lee HS, et al. Among authors: yang hb. PLoS One. 2013;8(2):e55522. doi: 10.1371/journal.pone.0055522. Epub 2013 Feb 20. PLoS One. 2013. PMID: 23437057 Free PMC article.

3

Generation of med28 specific monoclonal antibodies.

Yu MA, Cho JG, Kim KI, Jo YJ, Sung JH, Yang HB, Park SG. Yu MA, et al. Among authors: yang hb. Monoclon Antib Immunodiagn Immunother. 2015 Feb;34(1):30-5. doi: 10.1089/mab.2014.0068. Monoclon Antib Immunodiagn Immunother. 2015. PMID: 25723281 Free PMC article.

4

A Glycoengineered Interferon-β Mutein (R27T) Generates Prolonged Signaling by an Altered Receptor-Binding Kinetics.

Lee S, Son WS, Yang HB, Rajasekaran N, Kim SS, Hong S, Choi JS, Choi JY, Song K, Shin YK. Lee S, et al. Among authors: yang hb. Front Pharmacol. 2019 Jan 24;9:1568. doi: 10.3389/fphar.2018.01568. eCollection 2018. Front Pharmacol. 2019. PMID: 30733680 Free PMC article.

5

Development of Human Monoclonal Antibody for Claudin-3 Overexpressing Carcinoma Targeting.

Yang H, Park H, Lee YJ, Choi JY, Kim T, Rajasekaran N, Lee S, Song K, Hong S, Choi JS, Shim H, Kim YD, Hwang S, Choi YL, Shin YK. Yang H, et al. Biomolecules. 2019 Dec 28;10(1):51. doi: 10.3390/biom10010051. Biomolecules. 2019. PMID: 31905631 Free PMC article.

6

Molecular engineering of antibodies for site-specific conjugation to lipid polydopamine hybrid nanoparticles.

Yang H, Le QV, Shim G, Oh YK, Shin YK. Yang H, et al. Acta Pharm Sin B. 2020 Nov;10(11):2212-2226. doi: 10.1016/j.apsb.2020.07.006. Epub 2020 Jul 18. Acta Pharm Sin B. 2020. PMID: 33304787 Free PMC article.

7

Macrosphelide A Exhibits a Specific Anti-Cancer Effect by Simultaneously Inactivating ENO1, ALDOA, and FH.

Song K, Rajasekaran N, Chelakkot C, Lee HS, Paek SM, Yang H, Jia L, Park HG, Son WS, Kim YJ, Choi JS, Jeong HM, Suh YG, Yun H, Shin YK. Song K, et al. Pharmaceuticals (Basel). 2021 Oct 19;14(10):1060. doi: 10.3390/ph14101060. Pharmaceuticals (Basel). 2021. PMID: 34681284 Free PMC article.

8

Matrix metalloproteinase 11 (MMP11) in macrophages promotes the migration of HER2-positive breast cancer cells and monocyte recruitment through CCL2-CCR2 signaling.

Kang SU, Cho SY, Jeong H, Han J, Chae HY, Yang H, Sung CO, Choi YL, Shin YK, Kwon MJ. Kang SU, et al. Lab Invest. 2022 Apr;102(4):376-390. doi: 10.1038/s41374-021-00699-y. Epub 2021 Nov 13. Lab Invest. 2022. PMID: 34775491 Free article.

9

Selection Strategies and Practical Application of BRAF V600E-Mutated Non-Small Cell Lung Carcinoma.

Hwang I, Choi YL, Lee H, Hwang S, Lee B, Yang H, Chelakkot C, Han J. Hwang I, et al. Cancer Res Treat. 2022 Jul;54(3):782-792. doi: 10.4143/crt.2021.843. Epub 2021 Nov 23. Cancer Res Treat. 2022. PMID: 34844291 Free PMC article.

10

Relevance of Circulating Tumor Cells as Predictive Markers for Cancer Incidence and Relapse.

Chelakkot C, Yang H, Shin YK. Chelakkot C, et al. Pharmaceuticals (Basel). 2022 Jan 6;15(1):75. doi: 10.3390/ph15010075. Pharmaceuticals (Basel). 2022. PMID: 35056131 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

691 results

Search Page

Filters